Search alternatives:
significantly reported » significantly related (Expand Search), significantly restored (Expand Search), significantly predicted (Expand Search)
reported decrease » reported disease (Expand Search), reported depressive (Expand Search), reported case (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
Showing 221 - 240 results of 18,030 for search '(( significantly ((nn decrease) OR (a decrease)) ) OR ( significantly reported decrease ))', query time: 0.68s Refine Results
  1. 221
    BT9 reduces DAOY and D425 medulloblastoma cell invasion.

    BT9 reduces DAOY and D425 medulloblastoma cell invasion. by Zahra Motahari (6814013)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  2. 222
    The effect of MAGMAS inhibition on mitochondrial respiration and acidification rate in D425 cells.

    The effect of MAGMAS inhibition on mitochondrial respiration and acidification rate in D425 cells. by Zahra Motahari (6814013)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  3. 223
    MAGMAS inhibition reduces DAOY cells migration.

    MAGMAS inhibition reduces DAOY cells migration. by Zahra Motahari (6814013)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  4. 224
    BT9 did not improve survival in the orthotopic xenograft model of D425 medulloblastoma.

    BT9 did not improve survival in the orthotopic xenograft model of D425 medulloblastoma. by Zahra Motahari (6814013)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  5. 225
    Grade system.

    Grade system. by Zhuoyang Xia (21354186)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  6. 226
    Literature search.

    Literature search. by Zhuoyang Xia (21354186)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 227
    Study characteristics.

    Study characteristics. by Zhuoyang Xia (21354186)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 228
    Flowchart of literature retrieval.

    Flowchart of literature retrieval. by Zhuoyang Xia (21354186)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 229
    Data extraction.

    Data extraction. by Zhuoyang Xia (21354186)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 230
    Cochrane Collaboration’s risk of bias tool.

    Cochrane Collaboration’s risk of bias tool. by Zhuoyang Xia (21354186)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 231
    General procedure for the synthesis of B.

    General procedure for the synthesis of B. by Xueqin lu (22250795)

    Published 2025
    Save to List
    Saved in:
  12. 232
    Image 3_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg

    Image 3_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg by Ling Kui (6108440)

    Published 2025
    “…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
    Save to List
    Saved in:
  13. 233
    Image 4_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg

    Image 4_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg by Ling Kui (6108440)

    Published 2025
    “…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
    Save to List
    Saved in:
  14. 234
    Image 2_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg

    Image 2_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg by Ling Kui (6108440)

    Published 2025
    “…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
    Save to List
    Saved in:
  15. 235
    Table 2_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.docx

    Table 2_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.docx by Ling Kui (6108440)

    Published 2025
    “…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
    Save to List
    Saved in:
  16. 236
    Table 3_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx

    Table 3_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx by Ling Kui (6108440)

    Published 2025
    “…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
    Save to List
    Saved in:
  17. 237
    Table 1_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx

    Table 1_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx by Ling Kui (6108440)

    Published 2025
    “…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
    Save to List
    Saved in:
  18. 238
    Image 1_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg

    Image 1_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg by Ling Kui (6108440)

    Published 2025
    “…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
    Save to List
    Saved in:
  19. 239
    Table 4_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx

    Table 4_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx by Ling Kui (6108440)

    Published 2025
    “…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
    Save to List
    Saved in:
  20. 240
    Four grid table.

    Four grid table. by Xiaoling Zhong (181270)

    Published 2025
    Subjects:
    Save to List
    Saved in:

Search Tools: